Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1002 |
---|---|
Product Name | Anti-Human IL2RA Recombinant Antibody(Daclizumab) |
Molecular Name | Daclizumab |
Alias | Anti-IL2RA Recombinant Antibody, Research Grade Daclizumab |
CAS Number | 152923-56-3 |
Molecular Weight | 142.61 kDa |
Target | IL2RA[Homo sapiens] |
Isotype | IgG1 Kappa |
Clonity | Monoclonal |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Applications | ELISA, Neut, IF, IP, FCM, FuncS, MRI |
Buffer | PBS, pH7.5 |
Background | Daclizumab (trade name Zinbryta) is a therapeutic humanized monoclonal antibody which was used for the treatment of adults with relapsing forms of multiple sclerosis (MS). Daclizumab works by binding to CD25, the alpha subunit of the IL-2 receptor of T-cells. |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |